Healing effects of Aegle marmelos (L.) correa fruit extract on experimental colitis

Indian Journal of Experimental Biology

Volumn 51, Issue 2, 2013, Pages 157-164

  Gautam, M K ^a   Ghatule, R R ^a   Singh, A ^a   Purohit, V ^a   Gangwar, M ^a   Kumar, Mohan ^a   Goel, R K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Aegle marmelos; Antioxidants; Colitis; Free radicals; Fruit pulp; Myeloperoxidase

Indexed keywords

ANTIINFECTIVE AGENT; ANTIOXIDANT; FREE RADICAL; PLANT EXTRACT;

AEGLE; ANIMAL; ARTICLE; BACTERIUM; BODY WEIGHT; CHEMISTRY; COLITIS; COLON; DRINKING BEHAVIOR; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; FRUIT; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; PATHOLOGY; PHYTOTHERAPY; RAT; WOUND HEALING;

AEGLE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BACTERIA; BODY WEIGHT; COLITIS; COLON; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FEMALE; FREE RADICALS; FRUIT; MALE; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; WOUND HEALING;

EID: 84873913385     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Loftus EV & Sandborn WJ, Epidemiology of inflammatory bowel disease, Gastroenterol Clin North Am, 31 (2002) 1.
2. Kirsner JB & Shorter RG, Recent development in nonspecific inflammatory bowel disease (second of two parts), N Engl J Med, 306 (1982) 837.
3. Jewell DP & Patel C, Immunology of inflammatory bowel disease, Scand J Gastroentrol, 114 (1985) 119.
4. Millar AD, Rapton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ & Blke DR, Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis, Gut, 39 (1996) 407.
5. Baliga MS, Bhat HP, Joseph N, Fazal F, Phytochemistry and medicinal uses of the bael fruit (Aegle marmelos Correa): A concise review, Food Res Int, 44 (2011) 1768.
6. Das B & Das RD, Medicinal properties and chemical constituents of Aegle marmelos Correa, Indian Drugs, 32 (1995) 93.
7. Rahimi R, Nikfar S, Rezaie A & Abdollahi MA, Metaanalysis of antibiotic therapy for active ulcerative colitis, Dig Dis Sci, 52 (2007) 2920.
8. Stickel F & Schuppan D, Herbal medicine in the treatment of liver diseases, Dig Liver Dis, 39 (2007) 293.
9. Salari P, Rezaie A, Larijani B & Abdollahi M, A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis, Med Sci Monit, 14 (2008) RA37.
10. Langmead L & Rampton DS, Complementary and alternative therapies for inflammatory bowel disease, Aliment Pharmacol Ther, 23 (2006) 341.
11. http://herbalmedicine.suite101.com/
12. Morris G, Beck P, Herridge M, Depew W, Szewczuk M & Wallace J, Hapten-induced model of colonic inflammation and ulceration in the rat colon, Gastroenterology, 96 (1989) 795.
13. National Committee for Clinical Laboratory Standards NCCLS, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standardsfifth edition. NCCLS document M7-A5, (Wayne, PA, USA.) NCCLS, 2000.
14. Wiegand I, Hilpert K & Hancock REW, Agar and broth dilution methods to determine the minimal inhibitory concentration of antimicrobial substances, Nature Protocols, 3 (2008) 163.
15. Lowry OH, Rosenborough NJ, Farr AL & Randal RJ, Protein measurement with folin phenol reagent, J Biol Chem, 193 (1951) 265.
16. Ohkawa H, Ohishi N & Yagi K, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95 (1979) 351.
17. Miranda KM, Epsey MG & Wink DA, A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, Biol Chem, 5 (2001) 62.
18. Kakkar P, Das B & Viswanathan PN, A modified spectrophotometric assay of superoxide dismutase, Indian J Biochem Biophy, 21 (1984) 130.
19. Aebi HU, Catalase in Methods in enzymatic analysis, edited by HU Bergmeyer, (New York) (Academic Press), 3, 1983, 276.
20. Sedlak J & Lindsay RH, Estimation of total protein bound and nonprotien sulfhydryl groups in tissue with Ellman's reagent, Anal Biochem, 25 (1968) 192.
21. Bradley PD, Friebal DA & Christensen RD, Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker, J Invest Dermatol, 78 (1982) 206.
22. Elson CO, Sartor RB, Tennyson GS & Riddell H, Experimental models of inflammatory bowel disease, Gastroenterol, 109 (1995) 1344.
23. Stein J, Ries J & Barret K, Disruption of intestinal barrier function associated with experimental colitis: Possible role of mast cells, Am J Physiol, 274 (1998) G274.
24. Pratibha N, Saxena VS, Amit A, D'Souza P, Bagchi M & Bagchi D, Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis, Int J Tissue React, 26 (2004) 43.
25. Srikumar R, Jeya Parthasarathy N & Sheela Devi R, Immunomodulatory activity of triphala on neutrophil functions, Biol Pharm Bull, 28 (2005) 1398.
26. Arul V, Miyazaki S & Dhananjayan R, Studies on the antiinflammatory, antipyretic and analgesic properties of the leaves of Aegle marmelos Corr, J Ethnopharmacol, 96 (2005) 159.
27. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB & Bulkley GB, Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon, Pharmacol Ther, 53 (1992) 375.
28. Yamada T & Grisham MB, Pathogenesis of tissue injury: Role of reactive metabolites of oxygen and nitrogen. in Inflammatory bowel disease from bench to bedside edited by S R Targan & F Shanahan (Williams and Wilkins, Baltimore, MD) 1994, 133.
29. Boughton-Smith NK, Wallace JL, Morris GP & Whittle BJR, The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat, Br J Pharmacol, 94 (1988) 65.
30. Krawitz JE, Sharon P & Stenson F, Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity, Gastroenterol, 87 (1984) 1344.
31. Halliwell B, Albumin-an important extracellular antioxidant, Biochem Pharmacol, 37 (1988) 569.
32. Martin MC, Martinez A, Mendoza JL, Taxonera C, Diaz- Rubio M & Fernandez-Arquero M, Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility, Immunogenetics, 59 (2007) 833.
33. Parmar C & Kaushal MK, Aegle marmelos Correa, Wild fruits of the sub- Himalayan region (Kalyani publishers, New Delhi) 1982, 1.
34. Roy SK & Khurdiya DS, Other subtropical fruit, Handbook of fruit science and technology: Production, composition, storage and processing, edited by D K Salunkhe & S S Kadam, (New York) Marcel Dekker, 1995.
35. Suvimol C & Pranee A, Bioactive compounds and volatile compounds of Thai bael fruit (Aegle marmelos (L.) Correa) as a valuable source for functional food ingredients, Int Food Res J, 15 (2008) 45.
36. Maity P, Hansda D, Bandyopadhyay U & Mishra DK, Biological activities of crude extracts and chemical constituents of bael, Aegle marmelos (L.) Correa, Indian J Exp Bio, 47 (2009) 849.
37. Patel P & Asdaq SMB, Immunomodulatory activity of methanolic fruit extract of Aegle marmelos in experimental animals, Saudi Pharmaceutical, 3 (2010) 161.
38. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V & Ortner M, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122 (2002) 44.
39. Maheshwari VL, Joshi PV & Patil RH, In vitro anti diarrhoeal activity and toxicity profile of Aegle marmelos Correa ex. Roxb. dried fruit pulp, Nat Prod Rad, 8 (2009) 498.
40. Elsasser-Beile U, Von-Kleist S, Gerlach S, Gallati H & Monting JS, Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis, J Clin Lab Anal, 8 (1994) 447.
41. Scaldaferri F & Fiocchi C, Inflammatory bowel disease: progress and current concepts of etiopathogenesis, J Dig Dis, 8 (2007) 171.
42. Marano CW, Lewis SA, Garulacan AP, Soler LA & Mullin JM, Tumor necrosis factor-a increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line, J Membr Biol, 161 (1998) 263.